Clinical Trial Update: Anderson Circulating Tumor Cell Burden (CTCB) Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for the Anderson Circulating Tumor Cell Burden (CTCB) study was terminated with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Spinal Disease
• Vertebral Compression Fractures

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cancer, Spinal Disease | Phase 4 | Status: TERMINATED | Results posted: 2010-12-16